<DOC>
	<DOC>NCT01626456</DOC>
	<brief_summary>This study will evaluate the safety and durability of effect of ALKS 9072 (also known as ALKS 9070) during long-term treatment of subjects with stable schizophrenia.</brief_summary>
	<brief_title>A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>(Subjects who participated in ALK9072003) Completed the ALK9072003 Day 85 visit Continues to require treatment with an antipsychotic medication (New Subjects) On a stable dose of oral antipsychotic medication Diagnosis of chronic schizophrenia based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSMIV) criteria that is clinically stable Has been able to achieve outpatient status for more than 3 months prior to screening Body Mass Index (BMI) of 18.5 to 40.0 kg/m2 (inclusive) Resides in a stable living situation (Subjects who participated in ALK9072003) Abnormal clinical laboratory, vital sign, or electrocardiogram (ECG) finding during participation in study ALK9072003 that was clinically relevant and related to study drug Missed more than 1 scheduled study visit during participation in study ALK9072003 Has a significant or unstable medical condition that would preclude safe completion of the current study Subject is pregnant or breastfeeding Subject expects to be incarcerated in the next 12 months, or has pending legal action which may impact compliance with study participation or procedures (New Subjects) History of poor or inadequate clinical response to treatment with aripiprazole History of treatment resistance Diagnosis of current substance dependence (including alcohol) Pregnant, lactating, or breastfeeding Has received any longacting intramuscular antipsychotic medication within 60 days prior to screening Currently under involuntary hospitalization Current or expected incarceration Additional inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>